InvestSMART

ReNerve Limited (ASX: RNV) - Announcements

- Current share price for RNV : $0.080

ASX company news and announcements for ReNerve Limited (RNV) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ReNerve Limited (RNV) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ReNerve Limited (RNV), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ReNerve Limited (RNV)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$11 Change in substantial holding 17 Apr 2025 2:05PM $0.105 $0.080 fallen by 23.81%
$11 Expands Global Footprint with Strategic Partnership in India 10 Apr 2025 9:29AM $0.105 $0.080 fallen by 23.81%
$11 Response to ASX Aware Letter 31 Mar 2025 4:51PM $0.130 $0.080 fallen by 38.46%
$11 Clinical Outcome Demonstrates Material Benefits for Patients 28 Mar 2025 9:39AM $0.110 $0.080 fallen by 27.27%
$11 Notification of cessation of securities - RNV 26 Mar 2025 8:30AM $0.120 $0.080 fallen by 33.33%
$11 Change of Director's Interest Notice - J Chick 20 Mar 2025 8:21AM $0.115 $0.080 fallen by 30.43%
$11 Cleansing Notice 14 Mar 2025 8:25AM $0.105 $0.080 fallen by 23.81%
$11 Application for quotation of securities - RNV 14 Mar 2025 8:22AM $0.105 $0.080 fallen by 23.81%
$11 Proposed issue of securities - RNV 13 Mar 2025 8:21AM $0.115 $0.080 fallen by 30.43%
$11 Marketing Approval in Thailand & Initial Sales in Hong Kong 11 Mar 2025 9:52AM $0.125 $0.080 fallen by 36%
$11 ReNerve Receives Additional $139K R&D Refund 7 Mar 2025 9:53AM $0.130 $0.080 fallen by 38.46%
$11 1HFY25 Results Announcement 28 Feb 2025 9:45AM $0.135 $0.080 fallen by 40.74%
$11 1HFY25 Appendix 4D and Half Year Report 28 Feb 2025 9:44AM $0.135 $0.080 fallen by 40.74%
$11 ReNerve enters distribution partnership in Mexico 27 Feb 2025 9:46AM $0.143 $0.080 fallen by 43.86%
$11 Change of Director's Interest Notice - M Panaccio 14 Feb 2025 8:20AM $0.170 $0.080 fallen by 52.94%
$11 Change of Director's Interest Notice - J Chick 10 Feb 2025 9:32AM $0.170 $0.080 fallen by 52.94%
$11 Quarterly Investor Presentation 6 Feb 2025 10:29AM $0.135 $0.080 fallen by 40.74%
$11 Investor Webinar Update 31 Jan 2025 9:33AM $0.145 $0.080 fallen by 44.83%
$11 ReNerve - Q2 FY25 Activities Report & Appendix 4C 29 Jan 2025 9:57AM $0.135 $0.080 fallen by 40.74%
$11 Becoming a substantial holder 9 Jan 2025 3:42PM $0.145 $0.080 fallen by 44.83%
$11 Change in substantial holding 18 Dec 2024 12:01PM $0.150 $0.080 fallen by 46.67%
$11 Change of Director's Interest Notice - S Cooper 18 Dec 2024 12:01PM $0.150 $0.080 fallen by 46.67%
$11 Change in substantial holding 17 Dec 2024 11:51AM $0.150 $0.080 fallen by 46.67%
$11 Change of Director's Interest Notice - S Cooper 17 Dec 2024 11:48AM $0.150 $0.080 fallen by 46.67%
$11 Change in substantial holding 13 Dec 2024 10:55AM $0.145 $0.080 fallen by 44.83%

101 - 125 of 150 results

Page 5 of 6

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.